P1083: BRENTUXIMAB VEDOTIN, ETOPOSIDE, SOLUMEDROL, HIGH DOSE ARA-C & PLATINUM FOLLOWED BY HDT & APBSCT FOR REFRACTORY/RELAPSED HODGKIN LYMPHOMA PATIENTS: LONG-TERM RESULTS OF THE GELTAMO GROUP BRESHAP STUDY

ABSTRACT:

SUBMITTER: Garcia-Sanz R 

PROVIDER: S-EPMC9429181 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature